Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle

1 Imperial College London, National Heart and Lung Institute, Harefield Heart Science Centre, Harefield, Middlesex, United Kingdom; and 2 Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland Submitted 23 June 2004 ; accepted in final form 31 October 2004 Clenbuterol (Clen), a 2 -...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2005-03, Vol.288 (3), p.H1468-H1476
Hauptverfasser: Soppa, Gopal K. R, Smolenski, Ryszard T, Latif, Najma, Yuen, Ada H. Y, Malik, Aalya, Karbowska, Joanna, Kochan, Zdzislaw, Terracciano, Cesare M. N, Yacoub, Magdi H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H1476
container_issue 3
container_start_page H1468
container_title American journal of physiology. Heart and circulatory physiology
container_volume 288
creator Soppa, Gopal K. R
Smolenski, Ryszard T
Latif, Najma
Yuen, Ada H. Y
Malik, Aalya
Karbowska, Joanna
Kochan, Zdzislaw
Terracciano, Cesare M. N
Yacoub, Magdi H
description 1 Imperial College London, National Heart and Lung Institute, Harefield Heart Science Centre, Harefield, Middlesex, United Kingdom; and 2 Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland Submitted 23 June 2004 ; accepted in final form 31 October 2004 Clenbuterol (Clen), a 2 -agonist, is known to produce skeletal and myocardial hypertrophy. This compound has recently been used in combination with left ventricular assist devices for the treatment of end-stage heart failure to reverse or prevent the adverse effects of unloading-induced myocardial atrophy. However, the mechanisms of action of Clen on myocardial cells have not been fully elucidated. In an attempt to clarify this issue, we examined the effects of chronic administration of Clen on Ca 2+ handling and substrate preference in cardiac muscle. Rats were treated with either 2 mg·kg –1 ·day –1 Clen or saline (Sal) for 4 wk with the use of osmotic minipumps. Ventricular myocytes were enzymatically dissociated. Cells were field stimulated at 0.5, 1, and 2 Hz, and cytoplasmic Ca 2+ transients were monitored with the use of the fluorescent indicator indo-1 acetoxymethyl ester. Two-dimensional surface area and action potentials in current clamp were also measured. We found that in the Clen group there was significant hypertrophy at the organ and cellular levels compared with Sal. In Clen myocytes, the amplitude of the indo-1 ratio transients was significantly increased. Sarcoplasmic reticulum Ca 2+ content, estimated by rapid application of 20 mM caffeine, was significantly increased in the Clen group. The action potential was prolonged in the Clen group compared with Sal. Carbohydrate contribution to the tricarboxylic cycle (Krebs cycle) flux was increased several times in the Clen group. This increase was associated with decreased expression of peroxisome proliferator-activated receptor- . This study shows that chronic administration of Clen induces cellular hypertrophy and increases oxidative carbohydrate utilization together with an increase in sarcoplasmic reticulum Ca 2+ content, which results in increased amplitude of the Ca 2+ transients. These effects could be important when Clen is used in conjunction with left ventricular assist devices treatment. sarcoplasmic reticulum Ca 2+ content; tricarboxylic cycle; left ventricular assist devices Address for reprint requests and other correspondence: C. M. N. Terracciano, Imperial College London, National Heart and Lung Institute, Ha
doi_str_mv 10.1152/ajpheart.00624.2004
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67425295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17527633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-1cc44bd1ca8e6c3dc8ef20947dae1919dafc7eb4b1dde35cada77c77baf055203</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EokPhCZBQVuwy9U8cJ2KFqpYiVWJT1pZjX09cOXGwHcG8fT0_FDaIlSXf7zuy70HoPcFbQji9Uo_LCCrmLcYtbbYU4-YF2pQJrQln_Uu0waxldUsYv0BvUnrEGHPRstfognBOO8rIBu1urAWdUxVspccYZqcrZSY3u5Sjyi7Mx4mHeVgzxOCrcmPXWR9HajbVBFkNwbs0HUhlVp-rYlZaReOUrqY1Ff0temWVT_DufF6i77c3D9d39f23L1-vP9_XuulpronWTTMYolUHrWZGd2Ap7hthFJCe9EZZLWBoBmIMMK6VUUJoIQZlcfkTZpfo4yl3ieHHCinLySUN3qsZwppkKxrKac__CxLBaVkWKyA7gTqGlCJYuUQ3qbiXBMtDEfJ3EfJYhDwUUawP5_h1mMD8cc6bL8CnEzC63fjTRZDLuE8u-LDby9vV-wf4lZ-jaddJJu9I03ZyMbbYV_-2n9_zl8WeAIgsr4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17527633</pqid></control><display><type>article</type><title>Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Soppa, Gopal K. R ; Smolenski, Ryszard T ; Latif, Najma ; Yuen, Ada H. Y ; Malik, Aalya ; Karbowska, Joanna ; Kochan, Zdzislaw ; Terracciano, Cesare M. N ; Yacoub, Magdi H</creator><creatorcontrib>Soppa, Gopal K. R ; Smolenski, Ryszard T ; Latif, Najma ; Yuen, Ada H. Y ; Malik, Aalya ; Karbowska, Joanna ; Kochan, Zdzislaw ; Terracciano, Cesare M. N ; Yacoub, Magdi H</creatorcontrib><description>1 Imperial College London, National Heart and Lung Institute, Harefield Heart Science Centre, Harefield, Middlesex, United Kingdom; and 2 Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland Submitted 23 June 2004 ; accepted in final form 31 October 2004 Clenbuterol (Clen), a 2 -agonist, is known to produce skeletal and myocardial hypertrophy. This compound has recently been used in combination with left ventricular assist devices for the treatment of end-stage heart failure to reverse or prevent the adverse effects of unloading-induced myocardial atrophy. However, the mechanisms of action of Clen on myocardial cells have not been fully elucidated. In an attempt to clarify this issue, we examined the effects of chronic administration of Clen on Ca 2+ handling and substrate preference in cardiac muscle. Rats were treated with either 2 mg·kg –1 ·day –1 Clen or saline (Sal) for 4 wk with the use of osmotic minipumps. Ventricular myocytes were enzymatically dissociated. Cells were field stimulated at 0.5, 1, and 2 Hz, and cytoplasmic Ca 2+ transients were monitored with the use of the fluorescent indicator indo-1 acetoxymethyl ester. Two-dimensional surface area and action potentials in current clamp were also measured. We found that in the Clen group there was significant hypertrophy at the organ and cellular levels compared with Sal. In Clen myocytes, the amplitude of the indo-1 ratio transients was significantly increased. Sarcoplasmic reticulum Ca 2+ content, estimated by rapid application of 20 mM caffeine, was significantly increased in the Clen group. The action potential was prolonged in the Clen group compared with Sal. Carbohydrate contribution to the tricarboxylic cycle (Krebs cycle) flux was increased several times in the Clen group. This increase was associated with decreased expression of peroxisome proliferator-activated receptor- . This study shows that chronic administration of Clen induces cellular hypertrophy and increases oxidative carbohydrate utilization together with an increase in sarcoplasmic reticulum Ca 2+ content, which results in increased amplitude of the Ca 2+ transients. These effects could be important when Clen is used in conjunction with left ventricular assist devices treatment. sarcoplasmic reticulum Ca 2+ content; tricarboxylic cycle; left ventricular assist devices Address for reprint requests and other correspondence: C. M. N. Terracciano, Imperial College London, National Heart and Lung Institute, Harefield Heart Science Centre, Laboratory of Cellular Electrophysiology, Harefield Hospital, Harefield, Middlesex UB9 6JH, UK (E-mail: c.terracciano{at}imperial.ac.uk )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00624.2004</identifier><identifier>PMID: 15528231</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenergic beta-Agonists - pharmacology ; Age Factors ; Animals ; Atrophy ; Calcium - metabolism ; Carbohydrate Metabolism ; Citric Acid Cycle - physiology ; Clenbuterol - pharmacology ; Energy Metabolism - physiology ; Heart - drug effects ; Heart - physiology ; Heart-Assist Devices - adverse effects ; Hypertrophy ; Male ; Myocardial Contraction - drug effects ; Myocardium - metabolism ; Myocardium - pathology ; Oxidation-Reduction ; Rats ; Rats, Inbred Lew ; Ventricular Function, Left - drug effects</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2005-03, Vol.288 (3), p.H1468-H1476</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-1cc44bd1ca8e6c3dc8ef20947dae1919dafc7eb4b1dde35cada77c77baf055203</citedby><cites>FETCH-LOGICAL-c492t-1cc44bd1ca8e6c3dc8ef20947dae1919dafc7eb4b1dde35cada77c77baf055203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3026,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15528231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soppa, Gopal K. R</creatorcontrib><creatorcontrib>Smolenski, Ryszard T</creatorcontrib><creatorcontrib>Latif, Najma</creatorcontrib><creatorcontrib>Yuen, Ada H. Y</creatorcontrib><creatorcontrib>Malik, Aalya</creatorcontrib><creatorcontrib>Karbowska, Joanna</creatorcontrib><creatorcontrib>Kochan, Zdzislaw</creatorcontrib><creatorcontrib>Terracciano, Cesare M. N</creatorcontrib><creatorcontrib>Yacoub, Magdi H</creatorcontrib><title>Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>1 Imperial College London, National Heart and Lung Institute, Harefield Heart Science Centre, Harefield, Middlesex, United Kingdom; and 2 Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland Submitted 23 June 2004 ; accepted in final form 31 October 2004 Clenbuterol (Clen), a 2 -agonist, is known to produce skeletal and myocardial hypertrophy. This compound has recently been used in combination with left ventricular assist devices for the treatment of end-stage heart failure to reverse or prevent the adverse effects of unloading-induced myocardial atrophy. However, the mechanisms of action of Clen on myocardial cells have not been fully elucidated. In an attempt to clarify this issue, we examined the effects of chronic administration of Clen on Ca 2+ handling and substrate preference in cardiac muscle. Rats were treated with either 2 mg·kg –1 ·day –1 Clen or saline (Sal) for 4 wk with the use of osmotic minipumps. Ventricular myocytes were enzymatically dissociated. Cells were field stimulated at 0.5, 1, and 2 Hz, and cytoplasmic Ca 2+ transients were monitored with the use of the fluorescent indicator indo-1 acetoxymethyl ester. Two-dimensional surface area and action potentials in current clamp were also measured. We found that in the Clen group there was significant hypertrophy at the organ and cellular levels compared with Sal. In Clen myocytes, the amplitude of the indo-1 ratio transients was significantly increased. Sarcoplasmic reticulum Ca 2+ content, estimated by rapid application of 20 mM caffeine, was significantly increased in the Clen group. The action potential was prolonged in the Clen group compared with Sal. Carbohydrate contribution to the tricarboxylic cycle (Krebs cycle) flux was increased several times in the Clen group. This increase was associated with decreased expression of peroxisome proliferator-activated receptor- . This study shows that chronic administration of Clen induces cellular hypertrophy and increases oxidative carbohydrate utilization together with an increase in sarcoplasmic reticulum Ca 2+ content, which results in increased amplitude of the Ca 2+ transients. These effects could be important when Clen is used in conjunction with left ventricular assist devices treatment. sarcoplasmic reticulum Ca 2+ content; tricarboxylic cycle; left ventricular assist devices Address for reprint requests and other correspondence: C. M. N. Terracciano, Imperial College London, National Heart and Lung Institute, Harefield Heart Science Centre, Laboratory of Cellular Electrophysiology, Harefield Hospital, Harefield, Middlesex UB9 6JH, UK (E-mail: c.terracciano{at}imperial.ac.uk )</description><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Age Factors</subject><subject>Animals</subject><subject>Atrophy</subject><subject>Calcium - metabolism</subject><subject>Carbohydrate Metabolism</subject><subject>Citric Acid Cycle - physiology</subject><subject>Clenbuterol - pharmacology</subject><subject>Energy Metabolism - physiology</subject><subject>Heart - drug effects</subject><subject>Heart - physiology</subject><subject>Heart-Assist Devices - adverse effects</subject><subject>Hypertrophy</subject><subject>Male</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardium - metabolism</subject><subject>Myocardium - pathology</subject><subject>Oxidation-Reduction</subject><subject>Rats</subject><subject>Rats, Inbred Lew</subject><subject>Ventricular Function, Left - drug effects</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS0EokPhCZBQVuwy9U8cJ2KFqpYiVWJT1pZjX09cOXGwHcG8fT0_FDaIlSXf7zuy70HoPcFbQji9Uo_LCCrmLcYtbbYU4-YF2pQJrQln_Uu0waxldUsYv0BvUnrEGHPRstfognBOO8rIBu1urAWdUxVspccYZqcrZSY3u5Sjyi7Mx4mHeVgzxOCrcmPXWR9HajbVBFkNwbs0HUhlVp-rYlZaReOUrqY1Ff0temWVT_DufF6i77c3D9d39f23L1-vP9_XuulpronWTTMYolUHrWZGd2Ap7hthFJCe9EZZLWBoBmIMMK6VUUJoIQZlcfkTZpfo4yl3ieHHCinLySUN3qsZwppkKxrKac__CxLBaVkWKyA7gTqGlCJYuUQ3qbiXBMtDEfJ3EfJYhDwUUawP5_h1mMD8cc6bL8CnEzC63fjTRZDLuE8u-LDby9vV-wf4lZ-jaddJJu9I03ZyMbbYV_-2n9_zl8WeAIgsr4A</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>Soppa, Gopal K. R</creator><creator>Smolenski, Ryszard T</creator><creator>Latif, Najma</creator><creator>Yuen, Ada H. Y</creator><creator>Malik, Aalya</creator><creator>Karbowska, Joanna</creator><creator>Kochan, Zdzislaw</creator><creator>Terracciano, Cesare M. N</creator><creator>Yacoub, Magdi H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>7X8</scope></search><sort><creationdate>20050301</creationdate><title>Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle</title><author>Soppa, Gopal K. R ; Smolenski, Ryszard T ; Latif, Najma ; Yuen, Ada H. Y ; Malik, Aalya ; Karbowska, Joanna ; Kochan, Zdzislaw ; Terracciano, Cesare M. N ; Yacoub, Magdi H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-1cc44bd1ca8e6c3dc8ef20947dae1919dafc7eb4b1dde35cada77c77baf055203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Age Factors</topic><topic>Animals</topic><topic>Atrophy</topic><topic>Calcium - metabolism</topic><topic>Carbohydrate Metabolism</topic><topic>Citric Acid Cycle - physiology</topic><topic>Clenbuterol - pharmacology</topic><topic>Energy Metabolism - physiology</topic><topic>Heart - drug effects</topic><topic>Heart - physiology</topic><topic>Heart-Assist Devices - adverse effects</topic><topic>Hypertrophy</topic><topic>Male</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardium - metabolism</topic><topic>Myocardium - pathology</topic><topic>Oxidation-Reduction</topic><topic>Rats</topic><topic>Rats, Inbred Lew</topic><topic>Ventricular Function, Left - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soppa, Gopal K. R</creatorcontrib><creatorcontrib>Smolenski, Ryszard T</creatorcontrib><creatorcontrib>Latif, Najma</creatorcontrib><creatorcontrib>Yuen, Ada H. Y</creatorcontrib><creatorcontrib>Malik, Aalya</creatorcontrib><creatorcontrib>Karbowska, Joanna</creatorcontrib><creatorcontrib>Kochan, Zdzislaw</creatorcontrib><creatorcontrib>Terracciano, Cesare M. N</creatorcontrib><creatorcontrib>Yacoub, Magdi H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soppa, Gopal K. R</au><au>Smolenski, Ryszard T</au><au>Latif, Najma</au><au>Yuen, Ada H. Y</au><au>Malik, Aalya</au><au>Karbowska, Joanna</au><au>Kochan, Zdzislaw</au><au>Terracciano, Cesare M. N</au><au>Yacoub, Magdi H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>288</volume><issue>3</issue><spage>H1468</spage><epage>H1476</epage><pages>H1468-H1476</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><abstract>1 Imperial College London, National Heart and Lung Institute, Harefield Heart Science Centre, Harefield, Middlesex, United Kingdom; and 2 Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland Submitted 23 June 2004 ; accepted in final form 31 October 2004 Clenbuterol (Clen), a 2 -agonist, is known to produce skeletal and myocardial hypertrophy. This compound has recently been used in combination with left ventricular assist devices for the treatment of end-stage heart failure to reverse or prevent the adverse effects of unloading-induced myocardial atrophy. However, the mechanisms of action of Clen on myocardial cells have not been fully elucidated. In an attempt to clarify this issue, we examined the effects of chronic administration of Clen on Ca 2+ handling and substrate preference in cardiac muscle. Rats were treated with either 2 mg·kg –1 ·day –1 Clen or saline (Sal) for 4 wk with the use of osmotic minipumps. Ventricular myocytes were enzymatically dissociated. Cells were field stimulated at 0.5, 1, and 2 Hz, and cytoplasmic Ca 2+ transients were monitored with the use of the fluorescent indicator indo-1 acetoxymethyl ester. Two-dimensional surface area and action potentials in current clamp were also measured. We found that in the Clen group there was significant hypertrophy at the organ and cellular levels compared with Sal. In Clen myocytes, the amplitude of the indo-1 ratio transients was significantly increased. Sarcoplasmic reticulum Ca 2+ content, estimated by rapid application of 20 mM caffeine, was significantly increased in the Clen group. The action potential was prolonged in the Clen group compared with Sal. Carbohydrate contribution to the tricarboxylic cycle (Krebs cycle) flux was increased several times in the Clen group. This increase was associated with decreased expression of peroxisome proliferator-activated receptor- . This study shows that chronic administration of Clen induces cellular hypertrophy and increases oxidative carbohydrate utilization together with an increase in sarcoplasmic reticulum Ca 2+ content, which results in increased amplitude of the Ca 2+ transients. These effects could be important when Clen is used in conjunction with left ventricular assist devices treatment. sarcoplasmic reticulum Ca 2+ content; tricarboxylic cycle; left ventricular assist devices Address for reprint requests and other correspondence: C. M. N. Terracciano, Imperial College London, National Heart and Lung Institute, Harefield Heart Science Centre, Laboratory of Cellular Electrophysiology, Harefield Hospital, Harefield, Middlesex UB9 6JH, UK (E-mail: c.terracciano{at}imperial.ac.uk )</abstract><cop>United States</cop><pmid>15528231</pmid><doi>10.1152/ajpheart.00624.2004</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2005-03, Vol.288 (3), p.H1468-H1476
issn 0363-6135
1522-1539
language eng
recordid cdi_proquest_miscellaneous_67425295
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adrenergic beta-Agonists - pharmacology
Age Factors
Animals
Atrophy
Calcium - metabolism
Carbohydrate Metabolism
Citric Acid Cycle - physiology
Clenbuterol - pharmacology
Energy Metabolism - physiology
Heart - drug effects
Heart - physiology
Heart-Assist Devices - adverse effects
Hypertrophy
Male
Myocardial Contraction - drug effects
Myocardium - metabolism
Myocardium - pathology
Oxidation-Reduction
Rats
Rats, Inbred Lew
Ventricular Function, Left - drug effects
title Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T18%3A57%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20chronic%20administration%20of%20clenbuterol%20on%20function%20and%20metabolism%20of%20adult%20rat%20cardiac%20muscle&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Soppa,%20Gopal%20K.%20R&rft.date=2005-03-01&rft.volume=288&rft.issue=3&rft.spage=H1468&rft.epage=H1476&rft.pages=H1468-H1476&rft.issn=0363-6135&rft.eissn=1522-1539&rft_id=info:doi/10.1152/ajpheart.00624.2004&rft_dat=%3Cproquest_pubme%3E17527633%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17527633&rft_id=info:pmid/15528231&rfr_iscdi=true